FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224288570> ?p ?o ?g. }

• W4224288570 endingPage "937" @default.
• W4224288570 startingPage "937" @default.
• W4224288570 abstract "Representing an important cause of long–term disability, term neonatal hypoxic-ischemic encephalopathy (HIE) urgently needs further research aimed at repurposing existing drug as well as developing new therapeutics. Since various experimental in vitro and in vivo models of HIE have been developed with distinct characteristics, it becomes important to select the appropriate preclinical screening cascade for testing the efficacy of novel pharmacological treatments. As therapeutic hypothermia is already a routine therapy for neonatal encephalopathy, it is essential that hypothermia be administered to the experimental model selected to allow translational testing of novel or repurposed drugs on top of the standard of care. Moreover, a translational approach requires that therapeutic interventions must be initiated after the induction of the insult, and the time window for intervention should be evaluated to translate to real world clinical practice. Hippocampal organotypic slice cultures, in particular, are an invaluable intermediate between simpler cell lines and in vivo models, as they largely maintain structural complexity of the original tissue and can be subjected to transient oxygen–glucose deprivation (OGD) and subsequent reoxygenation to simulate ischemic neuronal injury and reperfusion. Progressing to in vivo models, generally, rodent (mouse and rat) models could offer more flexibility and be more cost-effective for testing the efficacy of pharmacological agents with a dose–response approach. Large animal models, including piglets, sheep, and non-human primates, may be utilized as a third step for more focused and accurate translational studies, including also pharmacokinetic and safety pharmacology assessments. Thus, a preclinical proof of concept of efficacy of an emerging pharmacological treatment should be obtained firstly in vitro, including organotypic models, and, subsequently, in at least two different animal models, also in combination with hypothermia, before initiating clinical trials." @default.
• W4224288570 created "2022-04-26" @default.
• W4224288570 creator A5041901658 @default.
• W4224288570 creator A5083113704 @default.
• W4224288570 creator A5087386233 @default.
• W4224288570 date "2022-04-19" @default.
• W4224288570 modified "2023-10-14" @default.
• W4224288570 title "Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy" @default.
• W4224288570 cites W1023249840 @default.
• W4224288570 cites W1112818150 @default.
• W4224288570 cites W1870861092 @default.
• W4224288570 cites W1966016110 @default.
• W4224288570 cites W1972090907 @default.
• W4224288570 cites W1972704887 @default.
• W4224288570 cites W1977841350 @default.
• W4224288570 cites W1980177483 @default.
• W4224288570 cites W1986609846 @default.
• W4224288570 cites W2011332518 @default.
• W4224288570 cites W2016955666 @default.
• W4224288570 cites W2026113882 @default.
• W4224288570 cites W2028972042 @default.
• W4224288570 cites W2032947046 @default.
• W4224288570 cites W2038521503 @default.
• W4224288570 cites W2045212640 @default.
• W4224288570 cites W2062430396 @default.
• W4224288570 cites W2062567045 @default.
• W4224288570 cites W2070513843 @default.
• W4224288570 cites W2078284510 @default.
• W4224288570 cites W2081797313 @default.
• W4224288570 cites W2094617144 @default.
• W4224288570 cites W2097047268 @default.
• W4224288570 cites W2099448554 @default.
• W4224288570 cites W2109557575 @default.
• W4224288570 cites W2115217673 @default.
• W4224288570 cites W2170277233 @default.
• W4224288570 cites W2319971109 @default.
• W4224288570 cites W2342456556 @default.
• W4224288570 cites W2344647123 @default.
• W4224288570 cites W2344792891 @default.
• W4224288570 cites W2346546808 @default.
• W4224288570 cites W2466214602 @default.
• W4224288570 cites W2555794385 @default.
• W4224288570 cites W2578717559 @default.
• W4224288570 cites W2582830902 @default.
• W4224288570 cites W2589493479 @default.
• W4224288570 cites W2592172081 @default.
• W4224288570 cites W2614045147 @default.
• W4224288570 cites W2625854121 @default.
• W4224288570 cites W2782638832 @default.
• W4224288570 cites W2783846599 @default.
• W4224288570 cites W2787879807 @default.
• W4224288570 cites W2789503898 @default.
• W4224288570 cites W2791608805 @default.
• W4224288570 cites W2793418966 @default.
• W4224288570 cites W2883002308 @default.
• W4224288570 cites W2883738215 @default.
• W4224288570 cites W2888563137 @default.
• W4224288570 cites W2888834232 @default.
• W4224288570 cites W2890597376 @default.
• W4224288570 cites W2895416642 @default.
• W4224288570 cites W2896741632 @default.
• W4224288570 cites W2900490565 @default.
• W4224288570 cites W2901573456 @default.
• W4224288570 cites W2939931005 @default.
• W4224288570 cites W2942868704 @default.
• W4224288570 cites W2946468377 @default.
• W4224288570 cites W2982378166 @default.
• W4224288570 cites W2988406672 @default.
• W4224288570 cites W2991250752 @default.
• W4224288570 cites W3107058825 @default.
• W4224288570 cites W3121849271 @default.
• W4224288570 cites W3124346278 @default.
• W4224288570 cites W3126214286 @default.
• W4224288570 cites W3138967848 @default.
• W4224288570 cites W3141266520 @default.
• W4224288570 cites W3170752721 @default.
• W4224288570 cites W3176260438 @default.
• W4224288570 cites W3205955396 @default.
• W4224288570 cites W3216594153 @default.
• W4224288570 cites W3217357875 @default.
• W4224288570 cites W4210664313 @default.
• W4224288570 cites W4210758561 @default.
• W4224288570 cites W5558027 @default.
• W4224288570 doi "https://doi.org/10.3390/biomedicines10050937" @default.
• W4224288570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35625674" @default.
• W4224288570 hasPublicationYear "2022" @default.
• W4224288570 type Work @default.
• W4224288570 citedByCount "6" @default.
• W4224288570 countsByYear W42242885702022 @default.
• W4224288570 countsByYear W42242885702023 @default.
• W4224288570 crossrefType "journal-article" @default.
• W4224288570 hasAuthorship W4224288570A5041901658 @default.
• W4224288570 hasAuthorship W4224288570A5083113704 @default.
• W4224288570 hasAuthorship W4224288570A5087386233 @default.
• W4224288570 hasBestOaLocation W42242885701 @default.
• W4224288570 hasConcept C126322002 @default.
• W4224288570 hasConcept C128544194 @default.
• W4224288570 hasConcept C142724271 @default.

• next